<div class="infobox infobox-gene">
| Gene | |
|---|---|
| Symbol | RPL27A |
| Full Name | Ribosomal Protein L27A |
| Chromosome | 16p13.3 |
| NCBI Gene ID | 6163 |
| UniProt ID | [P46776](https://www.uniprot.org/uniprotkb/P46776/entry) |
| Ensembl | [ENSG00000265391](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265391) |
</div>
<div class="infobox infobox-gene">
| Gene | |
|---|---|
| Symbol | RPL27A |
| Full Name | Ribosomal Protein L27A |
| Chromosome | 16p13.3 |
| NCBI Gene ID | 6163 |
| UniProt ID | [P46776](https://www.uniprot.org/uniprotkb/P46776/entry) |
| Ensembl | [ENSG00000265391](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265391) |
</div>
RPL27A (Ribosomal Protein L27A) encodes a component of the large 60S ribosomal subunit, essential for protein synthesis in all eukaryotic cells. This ribosomal protein is a member of the L27 family and plays a critical role in the structural integrity and function of the ribosome. While originally characterized as a housekeeping gene with ubiquitous expression, emerging research has revealed important functions for RPL27A in cancer biology, cellular stress responses, and potentially in age-related neurodegenerative diseases including Alzheimer's Disease and Parkinson's Disease.[@bhavsar2010]
The RPL27A gene is located on the short arm of chromosome 16 at position 13.3 (16p13.3), a region that has been implicated in various genetic disorders and cancer susceptibility.[@dekeersmaecker2015] The gene spans approximately 3.5 kb and consists of 6 exons encoding a 158-amino acid protein with a molecular weight of approximately 16.7 kDa. The genomic architecture is relatively simple, with short introns and a compact promoter region containing typical housekeeping gene features including multiple Sp1 binding sites and a CpG island.
Alternative splicing events affecting RPL27A have been documented, though their functional significance remains unclear. The gene is highly conserved across eukaryotes, with orthologs in yeast (Rpl27), Drosophila, zebrafish, and mice, reflecting its essential role in ribosome function. Phylogenetic analysis reveals that RPL27A belongs to a distinct ribosomal protein family that emerged early in eukaryotic evolution.
RPL27A is a small basic protein (pI ~10.5) that localizes to the large ribosomal subunit. The protein contains an N-terminal domain that interfaces with ribosomal RNA and a C-terminal domain that participates in protein-protein interactions within the ribosomal structure. Crystallographic studies of bacterial ribosomal proteins have provided insights into the general architecture, though specific structural details for RPL27A remain to be fully characterized.
Within the 60S subunit, RPL27A occupies a strategic position near the peptidyl transferase center (PTC), the catalytic core responsible for peptide bond formation. This location suggests potential roles in coordinating the peptidyl transferase reaction and maintaining the proper positioning of tRNA substrates during translation elongation.
RPL27A participates in several aspects of ribosomal function:
Ribosome Assembly: RPL27A is incorporated into the 60S subunit during the late stages of ribosome biogenesis. This process occurs in the nucleolus and requires numerous assembly factors. The protein stabilizes the subunit structure and contributes to proper rRNA folding.
Translation Elongation: In the mature ribosome, RPL27A contributes to the structural integrity of the peptidyl transferase center. Studies using ribosome profiling have identified RPL27A as important for maintaining translation fidelity, particularly at elongation rates.
tRNA Binding: The protein participates in coordinating tRNA positioning at the P-site (peptidyl site) and E-site (exit site), facilitating the translocation process during elongation.
Ribosome Recycling: After translation termination, RPL27A contributes to ribosome disassembly and recycling of ribosomal components.
RPL27A exhibits the expression pattern typical of housekeeping ribosomal protein genes, with ubiquitous expression across all tissues examined. Highest expression levels are found in tissues with high protein synthetic demands, including bone marrow, skeletal muscle, liver, and pancreas. Within the central nervous system, RPL27A is expressed in neurons and glia throughout the brain and spinal cord.
Expression studies using single-cell RNA sequencing reveal that RPL27A is expressed at moderate levels across all major brain cell types, including excitatory neurons, inhibitory neurons, astrocytes, microglia, and oligodendrocytes. This ubiquitous expression reflects the fundamental requirement for ribosomal function in all cell types.
During development, RPL27A expression is relatively constant, with only modest changes observed between fetal and adult tissues. However, cellular proliferation and cellular stress can modulate RPL27A expression, consistent with its roles in ribosome biogenesis and stress responses.
Beyond its canonical role in translation, RPL27A has been implicated in several extraribosomal functions that may be relevant to disease:
RPL27A has been shown to interact with MDM2, an E3 ubiquitin ligase that regulates p53 stability. Under certain conditions, RPL27A can compete with p53 for MDM2 binding, potentially modulating p53 levels and activity. This interaction is biologically significant because p53 is a key tumor suppressor and regulator of cellular stress responses. Dysregulation of this pathway could contribute to cancer progression or cellular dysfunction in neurodegeneration.
The so-called "ribosomal stress" or "nucleolar stress" pathway links ribosomal dysfunction to p53 activation. While this pathway is typically associated with ribosomal proteins RPL5, RPL11, and RPL23, RPL27A may also contribute under certain conditions. Ribosomal stress can be induced by various insults including chemotherapeutic agents, UV radiation, and nutrient deprivation.
RPL27A has been implicated in regulating apoptosis through its interactions with MDM2 and effects on p53. Additionally, ribosomal proteins can directly influence pro-apoptotic and anti-apoptotic signaling pathways independently of p53. The balance between pro-survival and pro-apoptotic signals is particularly important in neurons, which are highly vulnerable to ribosomal stress.
Emerging evidence suggests that ribosomal proteins, including RPL27A, may participate in DNA damage response pathways. This connection could be relevant to the accumulation of DNA damage observed in aging neurons and in neurodegenerative diseases.
Alterations in RPL27A expression and function have been documented in various cancers:
Dysregulated Expression: RPL27A expression is frequently upregulated in multiple cancer types including breast cancer, colorectal cancer, lung cancer, and leukemia. This overexpression likely reflects the increased protein synthetic demands of proliferating cancer cells.
Oncogenic Potential: Functional studies suggest that RPL27A can function as an oncogene in certain contexts. Overexpression of RPL27A can enhance cell proliferation and transform cells in culture. Conversely, knockdown of RPL27A can inhibit cancer cell growth and induce apoptosis.
Chemoresistance: RPL27A expression has been associated with chemoresistance in some cancer types. High RPL27A levels may enhance cancer cell survival by protecting against ribosomal stress induced by chemotherapeutic agents.
Prognostic Significance: In some cancers, high RPL27A expression correlates with poor prognosis, supporting its potential role as an oncogenic driver.
While not a classic disease gene, RPL27A may contribute to neurodegenerative disease pathogenesis through several mechanisms:
Ribosomal Dysfunction in Aging: Age-related decline in ribosomal function is a hallmark of cellular aging. Decreased RPL27A levels or function could contribute to the general decline in protein synthesis observed in aging neurons.
Alzheimer's Disease: Evidence suggests ribosomal dysfunction in AD brains, including reduced ribosome content, impaired translation, and altered expression of ribosomal proteins. Changes in RPL27A may contribute to these deficits.
Parkinson's Disease: Ribosomal abnormalities have been documented in PD models and patient tissue. The sensitivity of dopaminergic neurons to ribosomal stress makes RPL27A a potential contributor to PD pathogenesis.
Ribosomopathies: While classical ribosomopathies typically involve mutations in ribosomal protein genes causing bone marrow failure and cancer predisposition, RPL27A variants could theoretically contribute to neurodegeneration through haploinsufficiency or dominant-negative effects.
Ribosomal Biogenesis Disorders: Inherited defects in ribosome assembly can cause diseases collectively called ribosomopathies, characterized by bone marrow failure, developmental abnormalities, and cancer predisposition. RPL27A variants have not been definitively linked to human disease, but the possibility remains.
Aging: The ribosomal system is a key determinant of cellular aging. Declining ribosomal function contributes to the proteostasis collapse observed in aging cells and tissues.
Ribosome biogenesis is a tightly regulated process consuming substantial cellular resources. RPL27A expression is regulated at multiple levels:
Transcriptional Regulation: The RPL27A promoter contains binding sites for transcription factors involved in cell proliferation and metabolic regulation. MYC, a key oncogenic transcription factor, can directly activate RPL27A transcription.
Post-Translational Regulation: RPL27A is subject to post-translational modifications including phosphorylation and acetylation, which may regulate its incorporation into ribosomes or its extraribosomal functions.
Autoregulation: Like many ribosomal protein genes, RPL27A may participate in feedback loops that coordinate ribosomal protein production with cellular growth and division.
The MDM2-p53 pathway is a critical regulator of cellular stress responses and tumor suppression. RPL27A can modulate this pathway through several mechanisms:
Like other ribosomal proteins, RPL27A may be sequestered into stress granules under certain stress conditions. Stress granules are cytoplasmic membraneless organelles that accumulate translationally stalled mRNAs and associated proteins during cellular stress. While the significance of ribosomal protein inclusion in stress granules remains unclear, it may represent a mechanism for ribosomal quality control or stress response coordination.
RPL27A is not typically included in standard genetic testing panels for neurodegenerative diseases. However, research testing may be available:
RPL27A has been explored as a potential biomarker in some contexts:
RPL27A represents a potential therapeutic target in cancer:
Direct Targeting: While directly targeting ribosomal proteins is challenging due to their essential functions, compounds that specifically disrupt RPL27A's oncogenic functions could be developed.
Synthetic Lethality: Cancer cells with high RPL27A expression may be particularly vulnerable to ribosomal stress-inducing agents. This creates opportunities for synthetic lethal therapeutic strategies.
Chemotherapy Response: Understanding RPL27A's role in chemoresistance could guide treatment selection.
Therapeutic approaches targeting ribosomal dysfunction in neurodegeneration are under development:
Ribosome-Targeting Compounds: Drugs that enhance ribosomal function or protect against ribosomal stress are being investigated.
Gene Therapy: Delivery of RPL27A or related ribosomal proteins to neurons represents a potential approach.
Small Molecules: Compounds that enhance translation fidelity or reduce ribosomal stress could benefit neurons.
Mice lacking Rpl27a have been generated and reveal essential embryonic functions. Complete knockout results in embryonic lethality, demonstrating that Rpl27a is essential for development. Heterozygous mice are apparently normal but show subtle deficits in stress responses. Conditional knockout models in specific tissues, including neurons, are being developed to understand RPL27A's role in adult tissues and disease.
Zebrafish models have been used to study RPL27A function during development. Knockdown of rpl27a causes developmental abnormalities and defects in organogenesis, consistent with essential ribosomal functions.
Cell culture models including neuronal cell lines have been used to study RPL27A function. Overexpression and knockdown studies reveal roles in cell proliferation, stress responses, and viability.
Current research priorities include:
The following diagram shows the key molecular relationships involving RPL27A — Ribosomal Protein L27A discovered through SciDEX knowledge graph analysis: